MIT Sloan logo MIT logo

Research


Funding Translational Medicine via Public Markets: The Business Development Company

2015
Journal of Investment Management 13(2015), 9–32.
Sandra M. Forman, Monica Shilling, Grace K. Sweeney

Hedge Funds: A Dynamic Industry In Transition

2015
Annual Review of Financial Economics 7(2015), 483–577.
Mila Getmansky, Peter A. Lee

Financing Translation: Analysis of the NCATS Rare-Diseases Portfolio

2015
Science Translational Medicine 7(2015), 276ps3.
David E. Fagnan, N. Nora Yang, John C. McKew

Macroeconomic Modeling and Financial Stability: Lessons from the Crisis

2014

To Cure Cancer, Provide a Profit Motive

2014
Scientific American Forum
Roger M. Stein

Dealing with Femtorisks in International Relations

2014
Proceedings of the National Academy of Sciences 111(2014), 17356–17362.
Aaron Benjamin Frank, Margaret Goud Collins, Simon A. Levin, Andrew W. Lo, Joshua Ramo, Ulf Dieckmann, Victor Kremenyukf, Arkady Kryazhimskiy, JoAnne Linnerooth-Bayer, Ben Ramalingam, J. Stapleton Roy, Donald G. Saari, Stefan Thurner, and Detlof von Winterfeldt

Hedge Fund Beta Replication: A Five-Year Retrospective

2014
Journal of Investment Management 12(2014), 5–18
Peter A. Lee

Financing Drug Discovery for Orphan Diseases

2014
Drug Discovery Today 19 (2014), 533-538
David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein

Wall Street’s Next Bet: Cures for Rare Diseases

2014

New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.

2014
Journal of Investment Management
Sourya V. Naraharisetti

© 2020 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.